Complete versus partial distal embolic protection during renal stenting--as good or as worse?

Catheter Cardiovasc Interv. 2009 May 1;73(6):731-2. doi: 10.1002/ccd.22062.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Abciximab
  • Angioplasty, Balloon / adverse effects*
  • Angioplasty, Balloon / instrumentation*
  • Antibodies, Monoclonal / therapeutic use
  • Embolism / etiology
  • Embolism / prevention & control*
  • Evidence-Based Medicine
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use
  • Renal Artery Obstruction / therapy*
  • Renal Insufficiency / etiology
  • Renal Insufficiency / prevention & control*
  • Risk Assessment
  • Stents*
  • Time Factors
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Abciximab